Veeva Systems (VEEV) Stock Buyback History
TTM buyback yield 0.51% · Shareholder yield (TTM) 0.51%.
VEEV
TTM buyback yield
0.51%
Shareholder yield (TTM)
0.51%
5Y share count change
3.9%
TTM buyback spend
$169.95M
SBC coverage (TTM)
1.37x
YoY change in spend
N/A
5Y CAGR of spend
N/A
Peak year (2026)
$169.95M
Cumulative spend
$169.96M
TTM metrics calculated from the four most recent reported quarters, ending .
Key takeaways
- Veeva Systems (VEEV) repurchased about $169.95M of stock over the trailing twelve months.
- Diluted share count is up 3.9% over the last ~5 fiscal years — equity issuance and stock-based compensation are outpacing repurchases.
- TTM buyback ÷ stock-based-comp ratio of 1.37× — repurchases more than cover SBC dilution.
- TTM repurchases used about 12% of free cash flow remaining after dividends.
Buyback context per fiscal year
Annual repurchases alongside stock-based compensation, diluted share count and the year-over-year change — useful for SBC-coverage and dilution-offset reading at a glance.
| Year | Buybacks | SBC | Net | Shares (dil.) | YoY shares | Buyback yield |
|---|---|---|---|---|---|---|
| 2026 | $169.95M | $472.70M | −$302.75M | 0.17B | 1.1% | 0.51% |
| 2025 | $0.00 | $0.00 | $0.00 | 0.17B | 1.1% | — |
| 2024 | $0.00 | $0.00 | $0.00 | 0.16B | 0.6% | — |
| 2023 | $0.00 | $0.00 | $0.00 | 0.16B | 0.1% | — |
| 2022 | $0.00 | $0.00 | $0.00 | 0.16B | 1.0% | — |
| 2021 | $0.00 | $0.00 | $0.00 | 0.16B | 1.5% | — |
| 2020 | $0.00 | $0.00 | $0.00 | 0.16B | 1.4% | — |
| 2019 | $0.00 | $0.00 | $0.00 | 0.16B | 1.6% | — |
| 2018 | $0.00 | $0.00 | $0.00 | 0.15B | 4.1% | — |
| 2017 | $14.00K | $0.00 | $14.00K | 0.15B | 1.8% | 0.00% |
| 2016 | $0.00 | $0.00 | $0.00 | 0.14B | 0.5% | — |
| 2015 | $0.00 | $0.00 | $0.00 | 0.14B | 4.8% | — |
| 2014 | $0.00 | $0.00 | $0.00 | 0.14B | 9.4% | — |
| 2013 | $0.00 | $0.00 | $0.00 | 0.13B | 0.0% | — |
| 2012 | $0.00 | $434.00K | −$434.00K | 0.13B | 0.0% | — |
| 2011 | $0.00 | $169.00K | −$169.00K | 0.13B | — | — |
Cash buyback spend (USD) — annual & quarterly history
Trailing-twelve-month and per-period cash repurchases for Veeva Systems (VEEV) from the consolidated cash flow statement (line: common stock repurchased), in USD as filed.
Cash buyback spend over time for Veeva Systems (VEEV)
Per-period cash repurchases
Cash buyback spend annual + quarterly history for Veeva Systems (VEEV)
| Fiscal year | Period ended | Reported | Buyback Spend | YoY | YoY change |
|---|---|---|---|---|---|
| 2026 | $169.95M | — | +$169.95M | ||
| 2025 | $0 | — | $0 | ||
| 2024 | $0 | — | $0 | ||
| 2023 | $0 | — | $0 | ||
| 2022 | $0 | — | $0 | ||
| 2021 | $0 | — | $0 | ||
| 2020 | $0 | — | $0 | ||
| 2019 | $0 | — | $0 | ||
| 2018 | $0 | -100.0% | -$14,000 | ||
| 2017 | $14,000 | — | +$14,000 | ||
| 2016 | $0 | — | $0 | ||
| 2015 | $0 | — | $0 | ||
| 2014 | $0 | — | $0 | ||
| 2013 | $0 | — | $0 | ||
| 2012 | $0 | — | $0 | ||
| 2011 | $0 | — | — |
As of the 2026 fiscal year, Veeva Systems (VEEV) reported buyback spend of $169.95M.
$169.95M stands as the all-time-high annual buyback spend, posted in 2026, against a low of $0 during 2011.
Within Healthcare, Veeva Systems (VEEV) ranks 8th among 8 peers we track. The peer median for buyback spend is $2.75B.
Veeva Systems Buyback Spend 2026: $169.95M
Veeva Systems buyback spend in 2026 was $169.95M.
Veeva Systems Buyback Spend 2025: $0
Veeva Systems buyback spend in 2025 was $0.
Veeva Systems Buyback Spend 2024: $0
Veeva Systems buyback spend in 2024 was $0.
Veeva Systems Buyback Spend 2023: $0
Veeva Systems buyback spend in 2023 was $0.
Veeva Systems Buyback Spend 2022: $0
Veeva Systems buyback spend in 2022 was $0.
See more financial history for Veeva Systems (VEEV).
Sector peers by buyback spend
Companies in the same sector as Veeva Systems, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group (UNH) | $5.54B | Healthcare |
| Merck & Co. (MRK) | $5.08B | Healthcare |
| Eli Lilly (LLY) | $4.11B | Healthcare |
| Novo Nordisk (NVO) | $1.39B | Healthcare |
| AbbVie (ABBV) | $980.00M | Healthcare |
| AstraZeneca (AZN) | $719.66M | Healthcare |
| Amgen (AMGN) | $0 | Healthcare |
Share count history
Diluted weighted-average shares drive the EPS denominator and per-share capital-return maths. A falling diluted share count means buybacks are outpacing dilution from stock-based compensation and option exercises.
Diluted vs basic shares (annual)
Year-over-year change in diluted shares
Green is fewer shares vs the prior fiscal year (net repurchase); red is growth (dilution). The earliest year shown has no prior year to compare.
Dividend & buyback yield over time
Stacked annual yields — buyback yield (TTM cash repurchases ÷ market cap) plus dividend yield from the same fiscal-year-end key-metrics period — show how total cash return per dollar of equity has evolved.
Buybacks vs stock-based compensation
Annual cash repurchases set against stock-based compensation. Coverage above 1× means buybacks fully offset the equity dilution from SBC. TTM coverage: 1.37×.
Capital allocation mix
How Veeva Systems splits cash returned to shareholders between dividends and buybacks, plus the headroom on free cash flow that's still available for additional repurchases.
Buybacks vs dividends (share of cash returned)
Buyback capacity (TTM)
Free cash flow minus dividends paid versus actual TTM repurchases — the headroom bar shows how much of post-dividend FCF is still being deployed elsewhere.
Headroom $1.39B (TTM FCF − TTM dividends, clamped at zero).
Data & methodology
Where do buyback, dividend and compensation figures come from?
Cash buyback spend (common stock repurchased), dividends paid and stock-based compensation come from Veeva Systems's consolidated cash flow statements — quarterly 10-Q and annual 10-K SEC filings, in USD as reported.
How are diluted shares and yields calculated?
Diluted weighted-average share counts come from the income statement (EPS denominator). Trailing twelve-month (TTM) aggregates sum the four most recent reported quarters. Buyback and dividend yields divide TTM cash flows by market capitalisation at the latest quarter-end.
How is buyback capacity defined?
Capacity compares TTM repurchases to free cash flow after dividends: operating cash flow minus capital expenditure, minus dividends paid, versus actual buybacks over the same trailing window.
Is this investment advice?
No. Figures are for informational and educational use only. Past buybacks and dividends do not predict future returns.
Frequently asked questions
Does Veeva Systems buy back its own stock?
Yes, Veeva Systems (VEEV) has repurchased shares in recent periods. See the history table and charts on this page for amounts and trends.
How much does Veeva Systems spend on share buybacks?
Trailing twelve months (TTM) buyback spend is about $169.95M (sum of the last four quarterly cash-flow periods in our data). Figures are illustrative; verify in filings.
What is Veeva Systems's buyback yield?
TTM buyback yield is about 0.51% (TTM buyback spend divided by market cap at the latest quarter-end in our data).
What is Veeva Systems's shareholder yield?
Shareholder yield combines dividend yield and buyback yield. For the latest period we show approximately 0.51% combined (TTM-based where available).
Is Veeva Systems diluting shareholders?
Compare stock-based compensation (SBC) to buybacks in the chart above. Net effect varies by year; see annual buyback vs SBC bars and the history table.
How has Veeva Systems's share count changed?
Diluted weighted average shares changed by about 3.9% over roughly five fiscal years (annual income statement data).
What is Veeva Systems's buyback spend?
Latest reported buyback spend for Veeva Systems (VEEV) is $169.95M (period ending January 31, 2026).
When did Veeva Systems buyback spend hit its highest annual value?
Veeva Systems buyback spend reached its highest annual value of $169.95M in 2026.
What was Veeva Systems buyback spend in 2025?
Veeva Systems (VEEV) buyback spend in 2025 was $0.
What was Veeva Systems buyback spend in 2026?
Veeva Systems (VEEV) buyback spend in 2026 was $169.95M.
Explore more
VEEV Overview
Company profile, financial tools, and key metrics
VEEV What If Invested
What if you had invested $1,000? See historical returns from any date.
VEEV How It Makes Money
Discover visual breakdown — where revenue comes from and where it goes.
VEEV Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
VEEV Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
VEEV Daily Price Character
Balanced · 52.0% historical win rate (green days). Streaks & record days.
VEEV Financials
Revenue, EPS, EBITDA, market cap, debt and balance sheet history with annual and quarterly data.